Geode Capital Management, Mizuho Securities, and Manufacturers Life Insurance Company increased their holdings and raised their target price/rating on MBX Biosciences stock.
3 reports, 2 independent
Updated Nov 11
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Geode Capital Management, Mizuho Securities, and Manufacturers Life Insurance Company increased their holdings and raised their target price/rating on MBX Biosciences stock.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.UBS reissued a buy rating and several firms increased their stakes in MBX Biosciences.1 source
Increased holdings and raised target price/rating on MBX Biosciences stock.1 source
Keep exploring
The entities involved
-
Geode Capital Management
American Investment Management firm based in Boston, Massachusetts
Nothing else this week.
-
Mizuho Securities
Japanese investment banking company
-
Manufacturers Life Insurance Company
business
Nothing else this week.